The field of immunotherapy has revolutionized cancer treatment by harnessing the body's immune system to fight cancer cells. Nevertheless, we are still lacking biomarkers to stratify patients and predict therapy outcome. Imaging techniques such as Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and computed tomography (CT), play a crucial role in understanding the immune response within tumors and the efficacy of immunotherapies. This book, "Imaging Immunotherapies and Immune Response in Tumors," aims to provide a comprehensive guide on the intersection of imaging and immunotherapy, offering insights into current technologies, methodologies, clinical applications, and future directions.
Imaging Immunotherapies and Immune Response in Tumors aims to fill a critical gap in the current body of knowledge by providing a comprehensive and up-to-date resource on the research and clinical use of imaging in cancer immunotherapy. With its detailed coverage, multidisciplinary approach, clinical application, and future directions, this book will be an invaluable resource for healthcare professionals and researchers dedicated to advancing cancer treatment and improving patient outcomes. By addressing the latest advances and challenges in the field, this book will not only educate, but also inspire new research and clinical practice, ultimately contributing to the ongoing fight against cancer.
This research topic is designed to appeal to oncologists, radiologists, and cancer immunologists working with imaging and immunotherapies. Due to the relative youth of this field, there is still intense research into the mechanism of immunotherapies. This book is also intended for researchers with experience in imaging and oncology, both at the clinical and preclinical levels.
This Research Topic welcomes Commentaries, Original Research and Review articles, and Perspective and Opinion articles. It aims to cover, but is not limited to, the following subtopics:
• Imaging Tumor Immune Microenvironment (TIME)
• Imaging Biomarkers for Immune Response
• Advanced Imaging Technologies
• Imaging in Clinical Trials
• Challenges and Ethical Considerations.
This research topic is targeted at oncologists, radiologists, medical researchers, and healthcare professionals involved in cancer treatment and research. Additionally, it will be valuable to medical students, trainees, and academics interested in the latest advancements in cancer immunotherapy and imaging technologies.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
Immunotherapies, Immune response, Clinical Imaging, MRI, PET
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The field of immunotherapy has revolutionized cancer treatment by harnessing the body's immune system to fight cancer cells. Nevertheless, we are still lacking biomarkers to stratify patients and predict therapy outcome. Imaging techniques such as Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and computed tomography (CT), play a crucial role in understanding the immune response within tumors and the efficacy of immunotherapies. This book, "Imaging Immunotherapies and Immune Response in Tumors," aims to provide a comprehensive guide on the intersection of imaging and immunotherapy, offering insights into current technologies, methodologies, clinical applications, and future directions.
Imaging Immunotherapies and Immune Response in Tumors aims to fill a critical gap in the current body of knowledge by providing a comprehensive and up-to-date resource on the research and clinical use of imaging in cancer immunotherapy. With its detailed coverage, multidisciplinary approach, clinical application, and future directions, this book will be an invaluable resource for healthcare professionals and researchers dedicated to advancing cancer treatment and improving patient outcomes. By addressing the latest advances and challenges in the field, this book will not only educate, but also inspire new research and clinical practice, ultimately contributing to the ongoing fight against cancer.
This research topic is designed to appeal to oncologists, radiologists, and cancer immunologists working with imaging and immunotherapies. Due to the relative youth of this field, there is still intense research into the mechanism of immunotherapies. This book is also intended for researchers with experience in imaging and oncology, both at the clinical and preclinical levels.
This Research Topic welcomes Commentaries, Original Research and Review articles, and Perspective and Opinion articles. It aims to cover, but is not limited to, the following subtopics:
• Imaging Tumor Immune Microenvironment (TIME)
• Imaging Biomarkers for Immune Response
• Advanced Imaging Technologies
• Imaging in Clinical Trials
• Challenges and Ethical Considerations.
This research topic is targeted at oncologists, radiologists, medical researchers, and healthcare professionals involved in cancer treatment and research. Additionally, it will be valuable to medical students, trainees, and academics interested in the latest advancements in cancer immunotherapy and imaging technologies.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
Immunotherapies, Immune response, Clinical Imaging, MRI, PET
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.